BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2008
View Archived Issues
Potentially active ST-246 exposure levels achieved in phase I study
Read More
CMX-001 protects against herpes virus infection in mice
Read More
Celera grants Merck access to cancer targets for RNAi therapeutics
Read More
PAION to acquire CeNeS and discontinue development of neuroprotectant enecadin
Read More
Antisoma licenses rights to Betagenon's AMPK activators in cancer indications
Read More
Vicriviroc begins phase II study in treatment-naive HIV patients
Read More
Novel non-nucleoside reverse transcriptase inhibitor synthesized at Merck
Read More
Merck reports chemical structure of MK-0731
Read More
Basilea initiates additional phase III study of antifungal isavuconazole
Read More
Debiopharm enters license agreement with Airmid to develop ShK peptide Debio-0824
Read More
Biovitrum and Symphogen initiate clinical study of RhD polyclonal antibody Sym-001
Read More
OncoMed to provide SynCo with batches of antibody OMP-21M18 for phase I clinical trials
Read More
KV Pharmaceutical launches estradiol transdermal spray Evamist in the U.S.
Read More
Mundipharma reports results from study of Flutiform in asthmatic pediatric patients
Read More
Paratek's novel tetracycline derivative shows potential for treating spinal muscular atrophy
Read More
BHQ-880 effective in preclinical models of tumor-induced bone disease
Read More
Novel antiinfectious agents reported in recent Wockhardt and University of South Florida patents
Read More
New therapeutic options for gastrointestinal disorders described in recent patent literature
Read More
Recent patents disclose novel therapeutic agents for obesity and lipoprotein disorders
Read More
Theratechnologies treats last patient in phase III trial of tesamorelin in lipodystrophy
Read More
European orphan drug designations for farletuzumab and MORAb-009
Read More
Treximet receives FDA approval for acute treatment of migraine
Read More
Type 2 diabetes compound KB-3305 successfully completes first phase I study
Read More
ArQule decides against further clinical testing of ARQ-171
Read More
AEterna completes recruitment for first phase III cetrorelix trial in BPH
Read More